DNA and Gene Cloning Services Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: DNA and Gene Cloning Services Market covers analysis Product Type (Gene Synthesis, Custom Cloning, Sub-Cloning, Others); Application (DNA Sequencing, Mutagenesis, Genotyping, Others); End User (Academic and Research Institutes, Pharmaceutical and biotechnology companies, Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00029990
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

DNA and Gene Cloning Services Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET OVERVIEW

DNA and Gene cloning services are crucial in modern biotechnology and genetic research. These services involve isolating, amplifying, and manipulating specific DNA fragments or entire genes for various applications. They are utilized in medical research, pharmaceutical development, agricultural, and industrial biotechnology fields. With the advancement of DNA sequencing technology which provides accurate and high throughput sequencing data, the demand for DNA and gene cloning services has surged. These services enable scientists to study gene function, create custom DNA constructs, develop recombinant proteins, and explore genetic engineering projects.

The "Global DNA and Gene Cloning Services Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on global market trend analysis. The report aims to provide an overview of the DNA and gene cloning services market with detailed market segmentation by product type, application, end user, and geography. The report provides key statistics on the market status of the leading DNA and gene cloning services market players and offers key trends and opportunities in the market.

MARKET DRIVERS

Factors driving the DNA and gene cloning services market growth are the increase in R&D investment, the advancement of DNA sequencing technology, and the increase in the occurrence of infectious and chronic diseases. However, stringent management practices and high development costs for production.

The advancement of DNA sequencing technology is boosting the market growth. DNA sequencing is the process of determining the precise order of nucleotides in a DNA molecule, providing valuable insights into the genetic makeup of organisms. As sequencing technologies have become more advanced, faster, and more cost-effective, they have revolutionized the field of genomics and opened new possibilities for DNA and Gene Cloning Services. The availability of sequencing platforms has enabled researchers to generate vast amounts of genomic data with greater speed and accuracy. This wealth of information has fueled the demand for DNA and gene cloning services as scientists seek to understand the functional implications of specific genes and their infections within complex biological systems. As DNA sequencing technology continues to evolve, becoming more accurate, efficient, and affordable, the DNA and gene cloning services market is expected to grow further. Thus, the advancement of DNA sequencing technology is fueling the DNA and gene cloning services market growth.

GLOBAL SEGMENTAL ANALYSIS

The global DNA and gene cloning services market is segmented into product type, application, and end user. Based on product type, the DNA and gene cloning services market is segmented into gene synthesis, custom cloning, sub-cloning, and others. Based on application, the market is segmented into DNA sequencing, mutagenesis, and genotyping. Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, and others.

Based on application, the DNA sequencing segment dominates the market by gaining the maximum share of DNA and gene cloning services market. It has been possible to detect DNA changes due to rapid technological progress in sequence technology and bioinformatics. These developments have also identified variants related to an increase in disease risk. Other factors that drive the DNA Sequencing segment include technological progress, expansion of partnerships and alliances among leading players, and a global increase in initiatives to map the genetic material. For example, in June 2020 the Whitehead Institute for Biomedical Research in Massachusetts, US, has installed Illumina's NovaSeq 6000 Sequencing System at its center. Professor David Klenerman and Shankar Balasubramanian developed the next-generation DNA sequencing technology in 2020. Thus, the DNA sequencing segment drives the growth of DNA and gene cloning services market share.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry, including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. The DNA and gene cloning services market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & Central America after evaluating political, economic, social and technological factors affecting the DNA and gene cloning services market in these regions.

North America is estimated to account for a significant biologics contract manufacturing market share globally. This considerable percentage can be attributed to the increase in demand for DNA and gene cloning services. Furthermore, cloning and mutagenesis techniques are becoming more common in the region due to the increased adoption of platforms deriving from gynecologic and proteomic data. Increased product penetration was achieved due to the presence of world leaders in innovation and participants in the market. The Asian Pacific market is anticipated to grow rapidly due to increased demand for innovative treatments across the region. Also, some drivers that make regions prosperous include a stronger economy, increased government investment in R&D, and faster infrastructure development. In addition, funding is being made available to several regional actors to work on developing pharmaceutical treatments for certain long-term illnesses such as cancer.

World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry, including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. The DNA and gene cloning services market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & Central America after evaluating political, economic, social and technological factors affecting the DNA and gene cloning services market in these regions.

North America is estimated to account for a significant biologics contract manufacturing market share globally. This considerable percentage can be attributed to the increase in demand for DNA and gene cloning services. Furthermore, cloning and mutagenesis techniques are becoming more common in the region due to the increased adoption of platforms deriving from gynecologic and proteomic data. Increased product penetration was achieved due to the presence of world leaders in innovation and participants in the market. The Asian Pacific market is anticipated to grow rapidly due to increased demand for innovative treatments across the region. Also, some drivers that make regions prosperous include a stronger economy, increased government investment in R&D, and faster infrastructure development. In addition, funding is being made available to several regional actors to work on developing pharmaceutical treatments for certain long-term illnesses such as cancer.

MARKET PLAYERS

The report covers key developments in the DNA and gene cloning services market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the DNA and gene cloning services market are anticipated to have lucrative growth opportunities in the future with the rising demand for DNA and Gene Cloning Services in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the DNA and gene cloning services market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

- ADDGENE
- AMERICA DIAGNOSTICS
- AMID BIOSCIENCES
- AMSBIO
- BIO-FAB RESEARCH
- CAMBRIDGE BIOSCIENCE
- GENMAB
- PFIZER
- RD-BIOTECH
- SYNGENE

Recent Developments
- In January 2021, Codex DNA, Inc., a leader in the development of automated solutions for the on-demand synthesis of genes and mRNA, announced a strategic collaboration and licensing agreement with Pfizer to access and further develop Codex DNA's novel EDS technology for potential application by Pfizer for its mRNA-based vaccines and other biopharma products.

- In December 2021, AMSBIO has expanded its diverse custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. The affordability and fast turnaround of these CRISPR/Cas9 services are designed to accelerate genome editing research.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Table of Content
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. DNA and Gene Cloning Services Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. DNA and Gene Cloning Services Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. DNA and Gene Cloning Services Market - Global Market Analysis
6.1 DNA and Gene Cloning Services - Global Market Overview
6.2 DNA and Gene Cloning Services - Global Market and Forecast to 2030
7. DNA and Gene Cloning Services Market – Revenue Analysis (USD Million) – By Product Type, 2020-2030
7.1 Overview
7.2 Gene Synthesis
7.3 Custom Cloning
7.4 Sub-Cloning
7.5 Others
8. DNA and Gene Cloning Services Market – Revenue Analysis (USD Million) – By Application, 2020-2030
8.1 Overview
8.2 DNA Sequencing
8.3 Mutagenesis
8.4 Genotyping
8.5 Others
9. DNA and Gene Cloning Services Market – Revenue Analysis (USD Million) – By End User, 2020-2030
9.1 Overview
9.2 Academic and Research Institutes
9.3 Pharmaceutical and biotechnology companies
9.4 Others
10. DNA and Gene Cloning Services Market - Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
10.1 North America
10.1.1 North America DNA and Gene Cloning Services Market Overview
10.1.2 North America DNA and Gene Cloning Services Market Revenue and Forecasts to 2030
10.1.3 North America DNA and Gene Cloning Services Market Revenue and Forecasts and Analysis - By Product Type
10.1.4 North America DNA and Gene Cloning Services Market Revenue and Forecasts and Analysis - By Application
10.1.5 North America DNA and Gene Cloning Services Market Revenue and Forecasts and Analysis - By End User
10.1.6 North America DNA and Gene Cloning Services Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States DNA and Gene Cloning Services Market
10.1.6.1.1 United States DNA and Gene Cloning Services Market, by Product Type
10.1.6.1.2 United States DNA and Gene Cloning Services Market, by Application
10.1.6.1.3 United States DNA and Gene Cloning Services Market, by End User
10.1.6.2 Canada DNA and Gene Cloning Services Market
10.1.6.2.1 Canada DNA and Gene Cloning Services Market, by Product Type
10.1.6.2.2 Canada DNA and Gene Cloning Services Market, by Application
10.1.6.2.3 Canada DNA and Gene Cloning Services Market, by End User
10.1.6.3 Mexico DNA and Gene Cloning Services Market
10.1.6.3.1 Mexico DNA and Gene Cloning Services Market, by Product Type
10.1.6.3.2 Mexico DNA and Gene Cloning Services Market, by Application
10.1.6.3.3 Mexico DNA and Gene Cloning Services Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 Saudi Arabia
10.4.3 U.A.E
10.4.4 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Pre and Post Covid-19 Impact
12. Industry Landscape
12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments
13. Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration
14. DNA and Gene Cloning Services Market - Key Company Profiles
14.1 Addgene
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
Note - Similar information would be provided for below list of companies

14.2 America Diagnostics
14.3 Amid Biosciences
14.4 AMSBIO
14.5 Bio-Fab Research
14.6 Cambridge Bioscience
14.7 Genmab
14.8 Pfizer
14.9 RD-Biotech
14.10 Syngene
15. Appendix
15.1 Glossary
15.2 About The Insight Partners
15.3 Market Intelligence Cloud
NOTES
- The list of companies included in the scope are as per standard report format and the list can be modified/expanded as per client's requirement
- The sequence/list of companies do not represent their current position in the market.
- The list of countries provided in the report are part of standard report and can be customized as per client's requirement.


RELATED REPORTS
- XXXX XXXX Market
- XXXX XXXX Market

The List of Companies
1. Addgene
2. America Diagnostics
3. Amid Biosciences
4. AMSBIO
5. Bio-Fab Research
6. Cambridge Bioscience
7. Genmab
8. Pfizer
9. RD-Biotech
10. Syngene

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..